文献速递核素与放射性配体治疗放射性药物与辐射防护

90Y放射栓塞后PET/CT测量的肺剂量与放射性肺炎发生率

Lung Dose Measured on Postradioembolization 90Y PET/CT and Incidence of Radiation Pneumonitis.
PubMed 文献 · J Nucl Med · 2021-11-12

该研究回顾性分析8年间317例90Y肝放射栓塞操作,比较计划期99mTc-MAA平面显像预测肺平均剂量(LMDMAA)与治疗后90Y PET/CT测量的左肺平均剂量(LMDY-90)及放射性肺炎发生的关系。结果显示放射性肺炎罕见(<1%),LMDY-90低于12 Gy者均未发生放射性肺炎;3例LMDY-90>12 Gy者中2例发生放射性肺炎并死亡。

要点

  • 放射性肺炎是90Y放射栓塞罕见但可能致命的并发症,发生率<1%。
  • LMDY-90低于12 Gy的患者未发生放射性肺炎。
  • 3例LMDY-90>12 Gy者中2例发生放射性肺炎并死亡。

核心结论

  • 90Y放射栓塞后因肺分流导致的放射性肺炎罕见(<1%),LMDY-90低于12 Gy者未发生放射性肺炎。

研究设计与样本

  • 回顾性分析2012年2月至2020年9月8年间317例90Y肝放射栓塞操作。
  • 共272例患者接受90Y操作,其中63%使用玻璃微球,37%使用树脂微球。
  • 中位注射活度为1,974 MBq(范围242-9,538 MBq)。
  • 采用99mTc-MAA平面显像计算预测肺平均剂量(LMDMAA),采用治疗后90Y PET/CT计算左肺平均剂量(LMDY-90),以左肺作为代表性肺体积以补偿呼吸导致的肝脏头尾方向运动散射、主要影响右肺。

主要发现

  • LMDMAA中位值为3.5 Gy(范围0.2-89.0 Gy),14例操作LMDMAA>30 Gy。
  • LMDY-90中位值为1 Gy(范围0.0-22.1 Gy),无患者LMDY-90>30 Gy。
  • 3例LMDY-90>12 Gy者中,2例发生放射性肺炎并死亡:一例LMDY-90为22.1 Gy、LMDMAA为89 Gy;另一例LMDY-90为17.7 Gy、LMDMAA为34.1 Gy。
  • 第三例LMDY-90为18.4 Gy(LMDMAA 29.1 Gy),因疾病进展于治疗后2个月、影像评估前死亡。
  • LMDY-90低于12 Gy的患者均未发生放射性肺炎。

关键数值与推荐

  • 当前临床实践中,预测肺剂量>30 Gy被视为排除患者接受治疗的 criterion。
  • 本研究中14例操作LMDMAA>30 Gy。
  • 本研究中无患者LMDY-90>30 Gy。
  • LMDY-90低于12 Gy者未发生放射性肺炎。

临床怎么用

  • 当前临床实践以预测肺剂量>30 Gy作为排除90Y放射栓塞治疗的 criterion。
  • 治疗后90Y PET/CT测量的LMDY-90可用于评估放射性肺炎风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiation pneumonitis is a rare but possibly fatal side effect of 90Y radioembolization. It may occur 1-6 mo after therapy, if a significant part of the 90Y microspheres shunts to the lungs. In current clinical practice, a predicted lung dose greater than 30 Gy is considered a criterion to exclude patients from treatment. However, contrasting findings regarding the occurrence of radiation pneumonitis and lung dose were previously reported in the literature. In this study, the relationship between the lung dose and the eventual occurrence of radiation pneumonitis after 90Y radioembolization was investigated. Methods: We retrospectively analyzed 317 90Y liver radioembolization procedures performed during an 8-y period (February 2012 to September 2020). We calculated the predicted lung mean dose (LMD) using 99mTc-MAA planar scintigraphy (LMDMAA) acquired during the planning phase and left LMD (LMDY-90) using the 90Y PET/CT acquired after the treatment. For the lung dose computation, we used the left lung as the representative lung volume, to compensate for scatter from the liver moving in the craniocaudal direction because of breathing and mainly affecting the right lung. Results: In total, 272 patients underwent 90Y procedures, of which 63% were performed with glass microspheres and 37% with resin microspheres. The median injected activity was 1,974 MBq (range, 242-9,538 MBq). The median LMDMAA was 3.5 Gy (range, 0.2-89.0 Gy). For 14 procedures, LMDMAA was more than 30 Gy. Median LMDY-90 was 1 Gy (range, 0.0-22.1 Gy). No patients had an LMDY-90 of more than 30 Gy. Of the 3 patients with an LMDY-90 of more than 12 Gy, 2 patients (one with an LMDY-90 of 22.1 Gy and an LMDMAA of 89 Gy; the other with an LMDY-90 of 17.7 Gy and an LMDMAA of 34.1 Gy) developed radiation pneumonitis and consequently died. The third patient, with an LMDY-90 of 18.4 Gy (LMDMAA, 29.1 Gy), died 2 mo after treatment, before the imaging evaluation, because of progressive disease. Conclusion: The occurrence of radiation pneumonitis as a consequence of a lung shunt after 90Y radioembolization is rare (<1%). No radiation pneumonitis developed in patients with a measured LMDY-90 lower than 12 Gy.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Stella M, van Rooij R, Lam MGEH, et al. Lung Dose Measured on Postradioembolization 90Y PET/CT and Incidence of Radiation Pneumonitis. J Nucl Med. 2021. PMID: 34772794. doi:10.2967/jnumed.121.263143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。